Harold A. Saul, of the Tampa office, gave testimony before the Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee about the challenges of living with Polycystic Kidney Disease, its impact on his family and the need for approval of certain drugs to combat the disease.